News | Weill Department of Medicine

Diversity Week Presentation Highlights Cornell Center for Health Equity and Diversity Center of Excellence

Although only 5% of active physicians are African American and 5.8% are Latino (2019 AAMC Diversity in Medicine report), Weill Cornell Medicine is dedicating time, energy and empathy to build inclusive environments. In recognition of Weill Cornell Medicine’s recent Diversity Week, the Weill Department of Medicine’s Grand Rounds on April 9, 2025 focused on the extraordinary work of the Cornell Center for Health Equity (CCHEq) and the Diversity Center of Excellence (DCOE), both partially based in... Read More

Celebrating Match Day 2025!

Congratulations Class of 2025!The Weill Department of Medicine is thrilled to welcome 45 incoming residents this July! The Class of 2025 represents 34 different medical schools – with 6 from Weill Cornell Medical College. Match results this year were revealed simultaneously at noon Eastern time on March 21 to medical students nationwide. Nearly 47,200 graduating allopathic, international and osteopathic medical students from across the country (and Americans studying abroad) competed for 43,237... Read More

Upcoming symposium underscores crucial need to study women’s global health

The Women in Global Health Research’s upcoming intensive course on Global Infectious Diseases Across a Woman’s Lifespan, capped off by their 10th annual Scientific Symposium, takes place May 19-22, with the final day—May 22—open to the Weill Cornell Medicine community, including students and trainees. All are welcome to register.The selective four-day intensive course will include topics such as sex differences in global infectious diseases; host immunology across the woman's lifespan; and the... Read More

AI Meets Oncology: New Model Personalizes Bladder Cancer Treatment

Leveraging the power of AI and machine learning technologies, researchers co-lead by Dr. Bishoy Morris Faltas, the Gellert Family–John P. Leonard MD Research Scholar in Hematology and Medical Oncology in the division of Hematology & Medical Oncology, has developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy. The model harnesses whole-slide tumor imaging and gene expression analyses in a way that outperforms previous... Read More

Immune Complex Shaves Stem Cells to Protect against Cancer

A new preclinical study published Jan. 2 in Nature Immunology may lead to therapies that target the earliest stages of cancer, bolstering the idea the inflammasome has a dual role—that while promotes inflammation associated with poor outcomes in late cancer stages, early on it can help prevent cells from becoming cancerous in the first place.“What was striking was that the innate immune system, which includes the inflammasome, has a role beyond infection,” said lead author Dr. Julie Magarian... Read More

Islet Transplantation with Blood Vessel Cells Shows Promise to Treat Type 1 Diabetes

Findings published Jan. 29 in Science Advances from a team lead by senior author Dr. Shahin Rafii, chief of the division of Regenerative Medicine, found that adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which requires further development and testing, could someday enable the much wider use of islet transplants to cure diabetes.Islets, found in the... Read More

Digging Into a Decades-Old Hepatitis B Mystery Suggests a New Potential Treatment

A new multi-institution study led in part by Dr. Robert Schwartz, a virologist and Assistant Professor of Medicine in the division of Gastroenterology & Hepatology, is striving to answer a key biological question: how the hepatitis B virus (HBV) is able to establish infection in liver cells.The research – led in conjunction with teams lead by chemical biologist Dr. Yael David at Memorial Sloan Kettering Cancer Center (MSK) and Dr. Viviana Risca at The Rockefeller University - identified a... Read More

New Therapy May Effectively Control HIV in Uganda

A new multi-national, multi-institutional study led by senior author Dr. Guinevere Lee, Assistant Professor of Virology in Medicine in the division of Infectious Diseases in the Weill Department of Medicine, found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.The study, published Jan. 30 in the Journal of Antimicrobial Chemotherapy, adds to growing evidence that lenacapavir may be a powerful new tool in the global anti-HIV drug arsenal.... Read More

Dr. C. Richard Boland Receives Charles Maltz, M.D., Ph.D. Excellence in Teaching Award

Dr. C Richard BolandDr. Clement Richard Boland, Professor Emeritus of Medicine at the University of San Diego, received the Charles Maltz, M.D., Ph.D. Excellence in Teaching Award by the division of Gastroenterology & Hepatology in the Weill Department of Medicine during a special reception Feb. 12.The award is bestowed in memory of Dr. Charles Maltz, a faculty member in the division of Gastroenterology & Hepatology for nearly 30 years. A pillar within the Weill Department of Medicine,... Read More

Patient Perceptions of Provider Can Influence Outcomes

Research has shown that the relationship between a patient and their provider can significantly influence the quality of care outcomes. This is particularly evident when considering provider race concordance, which is the alignment of a patient’s race with that of their healthcare provider, according to a new study led by a Weill Cornell Medical College student. Research into this topic sheds light on the intersection of race, healthcare, and patient satisfaction, offering an understanding of... Read More